BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23233134)

  • 1. Interaction of DISC1 with the PTB domain of Tensin2.
    Goudarzi S; Smith LJ; Schütz S; Hafizi S
    Cell Mol Life Sci; 2013 May; 70(9):1663-72. PubMed ID: 23233134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual domains of Tensin2 exhibit distinct subcellular localisations and migratory effects.
    Hafizi S; Sernstad E; Swinny JD; Gomez MF; Dahlbäck B
    Int J Biochem Cell Biol; 2010 Jan; 42(1):52-61. PubMed ID: 19747564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure of the phosphotyrosine binding (PTB) domain of human tensin2 protein in complex with deleted in liver cancer 1 (DLC1) peptide reveals a novel peptide binding mode.
    Chen L; Liu C; Ko FC; Xu N; Ng IO; Yam JW; Zhu G
    J Biol Chem; 2012 Jul; 287(31):26104-14. PubMed ID: 22645138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protein-tyrosine kinase Syk interacts with the C-terminal region of tensin2.
    Moon KD; Zhang X; Zhou Q; Geahlen RL
    Biochim Biophys Acta; 2012 Feb; 1823(2):199-205. PubMed ID: 22019427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tensin2 variant 3 is associated with aggressive tumor behavior in human hepatocellular carcinoma.
    Yam JW; Ko FC; Chan CY; Yau TO; Tung EK; Leung TH; Jin DY; Ng IO
    Hepatology; 2006 Oct; 44(4):881-90. PubMed ID: 17006924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression.
    Yam JW; Ko FC; Chan CY; Jin DY; Ng IO
    Cancer Res; 2006 Sep; 66(17):8367-72. PubMed ID: 16951145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tensin2 reduces intracellular phosphatidylinositol 3,4,5-trisphosphate levels at the plasma membrane.
    Hafizi S; Gustafsson A; Oslakovic C; Idevall-Hagren O; Tengholm A; Sperandio O; Villoutreix BO; Dahlbäck B
    Biochem Biophys Res Commun; 2010 Aug; 399(3):396-401. PubMed ID: 20678486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function.
    Chan LK; Ko FC; Ng IO; Yam JW
    PLoS One; 2009; 4(5):e5572. PubMed ID: 19440389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tensin1 and a previously undocumented family member, tensin2, positively regulate cell migration.
    Chen H; Duncan IC; Bozorgchami H; Lo SH
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):733-8. PubMed ID: 11792844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tensin2 is a novel mediator in thrombopoietin (TPO)-induced cellular proliferation by promoting Akt signaling.
    Jung AS; Kaushansky A; Macbeath G; Kaushansky K
    Cell Cycle; 2011 Jun; 10(11):1838-44. PubMed ID: 21527831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. START-GAP1/DLC1 is localized in focal adhesions through interaction with the PTB domain of tensin2.
    Kawai K; Kitamura SY; Maehira K; Seike J; Yagisawa H
    Adv Enzyme Regul; 2010; 50(1):202-15. PubMed ID: 19895840
    [No Abstract]   [Full Text] [Related]  

  • 12. Solution structure of tensin2 SH2 domain and its phosphotyrosine-independent interaction with DLC-1.
    Dai K; Liao S; Zhang J; Zhang X; Tu X
    PLoS One; 2011; 6(7):e21965. PubMed ID: 21765928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The possible involvement of tensin2 in the expression and extension of nephrin by glomerular podocytes in mice.
    Kato T; Mizuno S; Taketo MM; Kurosawa TM
    Biomed Res; 2008 Dec; 29(6):279-87. PubMed ID: 19129671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of disrupted-in-schizophrenia 1-interacting protein girdin in postnatal development of the dentate gyrus.
    Enomoto A; Asai N; Namba T; Wang Y; Kato T; Tanaka M; Tatsumi H; Taya S; Tsuboi D; Kuroda K; Kaneko N; Sawamoto K; Miyamoto R; Jijiwa M; Murakumo Y; Sokabe M; Seki T; Kaibuchi K; Takahashi M
    Neuron; 2009 Sep; 63(6):774-87. PubMed ID: 19778507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dixdc1 is a critical regulator of DISC1 and embryonic cortical development.
    Singh KK; Ge X; Mao Y; Drane L; Meletis K; Samuels BA; Tsai LH
    Neuron; 2010 Jul; 67(1):33-48. PubMed ID: 20624590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1H, 15N and 13C chemical shift assignments of the SH2 domain of human tensin2 (TENC1).
    Chen L; Liu C; Rui F; Zhu G
    Biomol NMR Assign; 2011 Oct; 5(2):211-4. PubMed ID: 21461930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. START-GAP2/DLC2 is localized in focal adhesions via its N-terminal region.
    Kawai K; Seike J; Iino T; Kiyota M; Iwamae Y; Nishitani H; Yagisawa H
    Biochem Biophys Res Commun; 2009 Mar; 380(4):736-41. PubMed ID: 19250640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation.
    Morris JA; Kandpal G; Ma L; Austin CP
    Hum Mol Genet; 2003 Jul; 12(13):1591-608. PubMed ID: 12812986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and functional interaction of disrupted-in-schizophrenia 1 and amyloid precursor protein regulates neuronal migration during mammalian cortical development.
    Young-Pearse TL; Suth S; Luth ES; Sawa A; Selkoe DJ
    J Neurosci; 2010 Aug; 30(31):10431-40. PubMed ID: 20685985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolin-1 regulation of disrupted-in-schizophrenia-1 as a potential therapeutic target for schizophrenia.
    Kassan A; Egawa J; Zhang Z; Almenar-Queralt A; Nguyen QM; Lajevardi Y; Kim K; Posadas E; Jeste DV; Roth DM; Patel PM; Patel HH; Head BP
    J Neurophysiol; 2017 Jan; 117(1):436-444. PubMed ID: 27832597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.